ACE Global Equity and Santé Ventures led a $43m Series B round in Clairity.

ACE Global Equity and Santé Ventures, an investment firms, led a $43m Series B round in Clairity, an AI-driven precision health company, with participation from BCRF. “For decades, we have relied on mammography to detect cancer only after it is visible. With Clairity Breast, we can now use the same images to predict who may be at risk over the next five years, supporting earlier intervention, fewer late-stage diagnoses, and more lives saved. This is the future of breast cancer care: predictive, personalized, and preventive,” Connie Lehman, Clairity Founder.